Drug
ZL 6201
ZL 6201: highest development phase Phase 1, developed by Zai Lab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZL-6201 NCT07374848 | Phase 1 | Solid Tumors |
Latest
No recent events.
Follow ZL 6201 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.